SEC Comment Letter for BICYCLE THERAPEUTICS PLC (BCYC) (CIK 0001761612) (BCYC) — Jun 10, 2020
BICYCLE THERAPEUTICS PLC (BCYC) (CIK 0001761612)
Date: June 10, 2020 · CIK: 0001761612 · Accession: 0000000000-20-005156
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-238996
Letter
United States securities and exchange commission logo June 10, 2020 Kevin Lee, Ph.D., MBA Chief Executive Officer BICYCLE THERAPEUTICS PLC B900, Babraham Research Campus Cambridge CB22 3AT United Kingdom Re:BICYCLE THERAPEUTICS PLC Registration Statement on Form S-3 Filed June 5, 2020 File No. 333-238996 Dear Dr. Lee: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jaime L. Chase, Esq.
Show Raw Text
United States securities and exchange commission logo
June 10, 2020
Kevin Lee, Ph.D., MBA
Chief Executive Officer
BICYCLE THERAPEUTICS PLC
B900, Babraham Research Campus
Cambridge CB22 3AT
United Kingdom
Re:BICYCLE THERAPEUTICS PLC
Registration Statement on Form S-3
Filed June 5, 2020
File No. 333-238996
Dear Dr. Lee:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at 202-551-2544 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Jaime L. Chase, Esq.